NANOVIRICIDES, INC. Operating Expenses
NANOVIRICIDES, INC. (NNVC) reported Operating Expenses of $2.03 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-15
- NANOVIRICIDES, INC. operating expenses for the quarter ending 2026-03-31 was $2.03M, a 9.73% decline year-over-year.
- NANOVIRICIDES, INC. operating expenses for the quarter ending 2025-12-31 was $2.23M, a 8.46% increase year-over-year.
- NANOVIRICIDES, INC. operating expenses for the quarter ending 2025-09-30 was $1.80M, a 43.28% decline year-over-year.
- NANOVIRICIDES, INC. operating expenses for the quarter ending 2025-06-30 was $2.12M, a 11.53% decline year-over-year.
- NANOVIRICIDES, INC. operating expenses for fiscal 2025 was $9.59M, a 12.63% increase from fiscal 2024.
- NANOVIRICIDES, INC. operating expenses for fiscal 2024 was $8.52M, a 4.78% decline from fiscal 2023.
- NANOVIRICIDES, INC. operating expenses for fiscal 2023 was $8.94M, a 10.23% increase from fiscal 2022.
- NANOVIRICIDES, INC. operating expenses for fiscal 2022 was $8.11M, a 7.21% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 77 month | Operating Expenses 80 month | Operating Expenses 83 month | Operating Expenses 86 month | Operating Expenses 89 month | Operating Expenses 92 month | Operating Expenses 95 month | Operating Expenses 99 month | Operating Expenses 101 month | Operating Expenses 104 month | Operating Expenses 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-15 | $4.26M derived: sum of 2 quarters · filed 2026-05-15 | $6.06M 10-Q · filed 2026-05-15 | $8.18M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2025-12-31 | $2.23M 10-Q · filed 2026-02-17 | $4.03M 10-Q · filed 2026-02-17 | $6.15M derived: sum of 3 quarters · filed 2026-02-17 | $8.39M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-14 | $3.91M derived: sum of 2 quarters · filed 2025-11-14 | $6.16M derived: sum of 3 quarters · filed 2026-05-15 | $8.22M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2025-06-30 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $4.36M derived: sum of 2 quarters · filed 2026-05-15 | $6.42M derived: sum of 3 quarters · filed 2026-05-15 | $9.59M 10-K · filed 2025-09-29 | ||||||||||||||
| 2025-03-31 | $2.25M 10-Q · filed 2026-05-15 | $4.31M derived: sum of 2 quarters · filed 2026-05-15 | $7.48M 10-Q · filed 2026-05-15 | $9.87M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2024-12-31 | $2.06M 10-Q · filed 2026-02-17 | $5.23M 10-Q · filed 2026-02-17 | $7.62M derived: sum of 3 quarters · filed 2026-02-17 | $9.53M derived: sum of 4 quarters · filed 2026-02-17 | ||||||||||||||
| 2024-09-30 | $3.17M 10-Q · filed 2025-11-14 | $5.56M derived: sum of 2 quarters · filed 2025-11-14 | $7.47M derived: sum of 3 quarters · filed 2025-11-14 | $9.65M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||||
| 2024-06-30 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $4.30M derived: sum of 2 quarters · filed 2025-09-29 | $6.48M derived: sum of 3 quarters · filed 2025-09-29 | $8.52M 10-K · filed 2025-09-29 | ||||||||||||||
| 2024-03-31 | $1.91M 10-Q · filed 2025-05-15 | $4.09M derived: sum of 2 quarters · filed 2025-05-15 | $6.12M 10-Q · filed 2025-05-15 | $9.80M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||
| 2023-12-31 | $2.18M 10-Q · filed 2025-02-14 | $4.22M 10-Q · filed 2025-02-14 | $7.89M derived: sum of 3 quarters · filed 2025-02-14 | $9.70M derived: sum of 4 quarters · filed 2025-02-14 | ||||||||||||||
| 2023-09-30 | $2.03M 10-Q · filed 2024-11-14 | $5.71M derived: sum of 2 quarters · filed 2024-11-14 | $7.52M derived: sum of 3 quarters · filed 2024-11-14 | $9.35M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||
| 2023-06-30 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $5.49M derived: sum of 2 quarters · filed 2024-09-27 | $7.32M derived: sum of 3 quarters · filed 2024-09-27 | $8.94M 10-K · filed 2024-09-27 | ||||||||||||||
| 2023-03-31 | $1.81M 10-Q · filed 2024-05-15 | $3.64M derived: sum of 2 quarters · filed 2024-05-15 | $5.27M 10-Q · filed 2024-05-15 | $7.06M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||||
| 2022-12-31 | $1.83M 10-Q · filed 2024-02-14 | $3.46M 10-Q · filed 2024-02-14 | $5.25M derived: sum of 3 quarters · filed 2024-02-14 | $7.04M derived: sum of 4 quarters · filed 2024-02-14 | ||||||||||||||
| 2022-09-30 | $1.62M 10-Q · filed 2023-11-14 | $3.42M derived: sum of 2 quarters · filed 2023-11-14 | $5.20M derived: sum of 3 quarters · filed 2023-11-14 | $7.12M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||||
| 2022-06-30 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $3.58M derived: sum of 2 quarters · filed 2023-10-13 | $5.50M derived: sum of 3 quarters · filed 2023-10-13 | $8.11M 10-K · filed 2023-10-13 | ||||||||||||||
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-15 | $3.71M derived: sum of 2 quarters · filed 2023-05-15 | $6.32M 10-Q · filed 2023-05-15 | $8.40M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||
| 2021-12-31 | $1.92M 10-Q · filed 2023-02-14 | $4.53M 10-Q · filed 2023-02-14 | $6.61M derived: sum of 3 quarters · filed 2023-02-14 | $8.71M derived: sum of 4 quarters · filed 2023-02-14 | ||||||||||||||
| 2021-09-30 | $2.61M 10-Q · filed 2022-11-14 | $4.69M derived: sum of 2 quarters · filed 2022-11-14 | $6.79M derived: sum of 3 quarters · filed 2022-11-14 | $9.09M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||
| 2021-06-30 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | $4.18M derived: sum of 2 quarters · filed 2022-10-13 | $6.47M derived: sum of 3 quarters · filed 2022-10-13 | $8.74M 10-K · filed 2022-10-13 | ||||||||||||||
| 2021-03-31 | $2.11M 10-Q · filed 2022-05-16 | $4.40M derived: sum of 2 quarters · filed 2022-05-16 | $6.67M 10-Q · filed 2022-05-16 | $8.50M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||||
| 2020-12-31 | $2.29M 10-Q · filed 2022-02-14 | $4.56M 10-Q · filed 2022-02-14 | $6.39M derived: sum of 3 quarters · filed 2022-02-14 | $8.94M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||||
| 2020-09-30 | $2.27M 10-Q · filed 2021-11-15 | $4.10M derived: sum of 2 quarters · filed 2021-11-15 | $6.64M derived: sum of 3 quarters · filed 2021-11-15 | $8.28M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $4.37M derived: sum of 2 quarters · filed 2021-10-12 | $6.01M derived: sum of 3 quarters · filed 2021-10-12 | $8.00M 10-K · filed 2021-10-12 | ||||||||||||||
| 2020-03-31 | $2.54M 10-Q · filed 2021-05-14 | $4.18M derived: sum of 2 quarters · filed 2021-05-14 | $6.16M 10-Q · filed 2021-05-14 | $8.33M derived: sum of 4 quarters · filed 2021-10-12 | ||||||||||||||
| 2019-12-31 | $1.63M 10-Q · filed 2021-02-16 | $3.62M 10-Q · filed 2021-02-16 | $5.79M derived: sum of 3 quarters · filed 2021-10-12 | $7.87M derived: sum of 4 quarters · filed 2021-10-12 | ||||||||||||||
| 2019-09-30 | $1.99M 10-Q · filed 2020-11-16 | $4.16M derived: sum of 2 quarters · filed 2021-10-12 | $6.24M derived: sum of 3 quarters · filed 2021-10-12 | $8.61M derived: sum of 4 quarters · filed 2021-10-12 | ||||||||||||||
| 2019-06-30 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $4.25M derived: sum of 2 quarters · filed 2021-10-12 | $6.62M derived: sum of 3 quarters · filed 2021-10-12 | $8.66M 10-K · filed 2021-10-12 | ||||||||||||||
| 2019-03-31 | $2.08M 10-Q · filed 2020-06-22 | $4.45M derived: sum of 2 quarters · filed 2020-06-22 | $6.49M 10-Q · filed 2020-06-22 | $8.77M derived: sum of 4 quarters · filed 2020-10-13 | ||||||||||||||
| 2018-12-31 | $2.37M 10-Q · filed 2020-02-14 | $4.41M 10-Q · filed 2020-02-14 | $6.69M derived: sum of 3 quarters · filed 2020-10-13 | $9.11M derived: sum of 4 quarters · filed 2020-10-13 | ||||||||||||||
| 2018-09-30 | $2.04M 10-Q · filed 2019-11-15 | $4.32M derived: sum of 2 quarters · filed 2020-10-13 | $6.74M derived: sum of 3 quarters · filed 2020-10-13 | $9.13M derived: sum of 4 quarters · filed 2020-10-13 | ||||||||||||||
| 2018-06-30 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $4.70M derived: sum of 2 quarters · filed 2020-10-13 | $7.09M derived: sum of 3 quarters · filed 2020-10-13 | $9.33M 10-K · filed 2020-10-13 | ||||||||||||||
| 2018-03-31 | $2.42M 10-Q · filed 2019-05-15 | $4.81M derived: sum of 2 quarters · filed 2019-05-15 | $7.04M 10-Q · filed 2019-05-15 | $9.29M derived: sum of 4 quarters · filed 2019-08-23 | ||||||||||||||
| 2017-12-31 | $2.39M 10-Q · filed 2019-02-14 | $4.62M 10-Q · filed 2019-02-14 | $6.87M derived: sum of 3 quarters · filed 2019-08-23 | $9.49M derived: sum of 4 quarters · filed 2019-08-23 | ||||||||||||||
| 2017-09-30 | $2.23M 10-Q · filed 2018-11-14 | $4.48M derived: sum of 2 quarters · filed 2019-08-23 | $7.09M derived: sum of 3 quarters · filed 2019-08-23 | $9.39M derived: sum of 4 quarters · filed 2019-08-23 | ||||||||||||||
| 2017-06-30 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $4.86M derived: sum of 2 quarters · filed 2019-08-23 | $7.16M derived: sum of 3 quarters · filed 2019-08-23 | $9.60M 10-K · filed 2019-08-23 | ||||||||||||||
| 2017-03-31 | $2.62M 10-Q · filed 2018-05-21 | $4.91M derived: sum of 2 quarters · filed 2018-05-21 | $7.35M 10-Q · filed 2018-05-21 | $9.85M derived: sum of 4 quarters · filed 2018-10-12 | ||||||||||||||
| 2016-12-31 | $2.30M 10-Q · filed 2018-02-20 | $4.74M 10-Q · filed 2018-02-20 | $7.23M derived: sum of 3 quarters · filed 2018-10-12 | $9.28M derived: sum of 4 quarters · filed 2018-10-12 | ||||||||||||||
| 2016-09-30 | $2.44M 10-Q · filed 2017-11-14 | $4.94M derived: sum of 2 quarters · filed 2018-10-12 | $6.98M derived: sum of 3 quarters · filed 2018-10-12 | $9.07M derived: sum of 4 quarters · filed 2018-10-12 | ||||||||||||||
| 2016-06-30 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $4.54M derived: sum of 2 quarters · filed 2018-10-12 | $6.63M derived: sum of 3 quarters · filed 2018-10-12 | $8.86M 10-K · filed 2018-10-12 | ||||||||||||||
| 2016-03-31 | $2.05M 10-Q · filed 2017-05-15 | $4.14M derived: sum of 2 quarters · filed 2017-05-15 | $6.36M 10-Q · filed 2017-05-15 | $8.97M derived: sum of 4 quarters · filed 2017-09-28 | ||||||||||||||
| 2015-12-31 | $2.09M 10-Q · filed 2017-02-14 | $4.32M 10-Q · filed 2017-02-14 | $6.92M derived: sum of 3 quarters · filed 2017-09-28 | $8.04M derived: sum of 4 quarters · filed 2017-09-28 | ||||||||||||||
| 2015-09-30 | $2.23M 10-Q · filed 2016-11-14 | $4.83M derived: sum of 2 quarters · filed 2017-09-28 | $5.95M derived: sum of 3 quarters · filed 2017-09-28 | $7.65M derived: sum of 4 quarters · filed 2017-09-28 | ||||||||||||||
| 2015-06-30 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $3.73M derived: sum of 2 quarters · filed 2017-09-28 | $5.43M derived: sum of 3 quarters · filed 2017-09-28 | $7.06M 10-K · filed 2017-09-28 | ||||||||||||||
| 2015-03-31 | $1.12M 10-Q · filed 2016-05-10 | $2.83M derived: sum of 2 quarters · filed 2016-05-10 | $4.46M 10-Q · filed 2016-05-10 | $4.63M 10-Q · filed 2015-05-15 | $8.31M derived: sum of 4 quarters · filed 2016-09-16 | |||||||||||||
| 2014-12-31 | $1.70M 10-Q · filed 2016-02-09 | $1.82M 10-Q · filed 2015-02-25 | $3.32M 10-Q · filed 2016-02-09 | $3.50M 10-Q · filed 2015-02-25 | $7.18M derived: sum of 3 quarters · filed 2016-09-16 | $8.42M derived: sum of 4 quarters · filed 2016-09-16 | ||||||||||||
| 2014-09-30 | $1.69M 10-Q · filed 2015-11-09 | $5.48M derived: sum of 2 quarters · filed 2016-09-16 | $6.71M derived: sum of 3 quarters · filed 2016-09-16 | $8.47M derived: sum of 4 quarters · filed 2016-09-16 | ||||||||||||||
| 2014-06-30 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $5.03M derived: sum of 2 quarters · filed 2016-09-16 | $6.78M derived: sum of 3 quarters · filed 2016-09-16 | $8.67M 10-K · filed 2016-09-16 | ||||||||||||||
| 2014-03-31 | $1.23M 10-Q · filed 2015-05-15 | $2.98M derived: sum of 2 quarters · filed 2015-05-15 | $4.87M 10-Q · filed 2015-05-15 | $6.44M derived: sum of 4 quarters · filed 2015-09-14 | $40.27M 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | $1.75M 10-Q · filed 2015-02-25 | $3.64M 10-Q · filed 2015-02-25 | $5.20M derived: sum of 3 quarters · filed 2015-09-14 | $7.39M derived: sum of 4 quarters · filed 2015-09-14 | $39.04M 10-Q · filed 2014-02-14 | |||||||||||||
| 2013-09-30 | $1.89M 10-Q/A · filed 2015-02-23 | $3.45M derived: sum of 2 quarters · filed 2015-09-14 | $5.64M derived: sum of 3 quarters · filed 2015-09-14 | $6.89M derived: sum of 4 quarters · filed 2015-09-14 | $37.29M 10-Q/A · filed 2013-11-18 | |||||||||||||
| 2013-06-30 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $3.75M derived: sum of 2 quarters · filed 2015-09-14 | $5.00M derived: sum of 3 quarters · filed 2015-09-14 | $6.59M 10-K · filed 2015-09-14 | $35.40M 10-K/A · filed 2013-10-08 | |||||||||||||
| 2013-03-31 | $2.19M 10-Q · filed 2014-05-15 | $3.43M derived: sum of 2 quarters · filed 2014-05-15 | $5.03M 10-Q · filed 2014-05-15 | $6.57M derived: sum of 4 quarters · filed 2015-02-23 | $33.84M 10-Q/A · filed 2013-05-20 | |||||||||||||
| 2012-12-31 | $1.24M 10-Q · filed 2014-02-14 | $2.84M 10-Q · filed 2014-02-14 | $4.38M derived: sum of 3 quarters · filed 2015-02-23 | $6.46M derived: sum of 4 quarters · filed 2015-02-23 | $31.64M 10-Q/A · filed 2013-02-22 | |||||||||||||
| 2012-09-30 | $1.59M 10-Q/A · filed 2013-11-18 | $3.14M derived: sum of 2 quarters · filed 2015-02-23 | $5.22M derived: sum of 3 quarters · filed 2015-02-23 | $6.55M derived: sum of 4 quarters · filed 2015-02-23 | $30.40M 10-Q · filed 2012-11-19 | |||||||||||||
| 2012-06-30 | $1.55M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | $3.62M derived: sum of 2 quarters · filed 2015-02-23 | $4.96M derived: sum of 3 quarters · filed 2015-02-23 | $6.08M 10-K · filed 2015-02-23 | $28.81M 10-K/A · filed 2012-10-26 | |||||||||||||
| 2012-03-31 | $2.08M 10-Q/A · filed 2013-05-20 | $3.41M derived: sum of 2 quarters · filed 2013-05-20 | $4.53M 10-Q/A · filed 2013-05-20 | $5.82M derived: sum of 4 quarters · filed 2013-05-20 | $27.26M 10-Q · filed 2012-05-21 | |||||||||||||
| 2011-12-31 | $1.34M 10-Q/A · filed 2013-02-22 | $2.46M 10-Q/A · filed 2013-02-22 | $3.74M derived: sum of 3 quarters · filed 2013-02-22 | $6.30M derived: sum of 4 quarters · filed 2013-02-22 | $25.18M 10-Q · filed 2012-02-14 | |||||||||||||
| 2011-09-30 | $1.14M 10-Q · filed 2012-11-19 | $2.40M derived: sum of 2 quarters · filed 2012-11-19 | $4.96M derived: sum of 3 quarters · filed 2012-11-19 | $6.46M derived: sum of 4 quarters · filed 2012-11-19 | $23.87M 10-Q/A · filed 2011-12-12 | |||||||||||||
| 2011-06-30 | $1.26M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $3.82M derived: sum of 2 quarters · filed 2012-10-26 | $5.32M derived: sum of 3 quarters · filed 2012-10-26 | $6.43M 10-K/A · filed 2012-10-26 | ||||||||||||||
| 2011-03-31 | $2.56M 10-Q · filed 2012-05-21 | $4.06M derived: sum of 2 quarters · filed 2012-05-21 | $5.17M 10-Q · filed 2012-05-21 | |||||||||||||||
| 2010-12-31 | $1.50M 10-Q · filed 2012-02-14 | $2.61M 10-Q · filed 2012-02-14 | ||||||||||||||||
| 2010-09-30 | $1.11M 10-Q/A · filed 2011-12-12 | |||||||||||||||||
| 2010-06-30 | $4.94M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |